-
May 8, 2018 Lupin submits New Drug Application for Etanercept biosimilar in Japan
-
May 7, 2018 Lupin receives FDA approval for generic Temovate Ointment, 0.05%
-
April 23, 2018 Lupin receives FDA approval for generic Xenazine® Tablets, 12.5 mg and 25 mg
-
April 17, 2018 Lupin receives tentative FDA approval for generic AndroGel®, 1.62%
-
April 9, 2018 Lupin’s Softovac in The Economic Times ‘Promising Brands of 2018’
-
April 6, 2018 Lupin’s Pithampur Unit 1 facility receives Establishment Investigation report (EIR) from US FDA
-
April 3, 2018 Lupin’s Goa facility completes successful UK MHRA inspection
-
April 2, 2018 Lupin’s Pithampur Unit cleared by Health Canada
-
March 29, 2018 Lupin launches generic Clobex® Spray, 0.05% in the US
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications